Inscripta IPO

inscripta.com

Inscripta is the developer of a benchtop platform for scalable digital genome engineering consisting of an instrument, consumables, software, and assays, that offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale.

Founded2015
Total Funding to Date$459.69MM
Register for Details

For more details on financing and valuation for Inscripta, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Inscripta Ticker Symbol

Inscripta does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Inscripta Stock Price

The stock price for Inscripta will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Major Investors for Inscripta

Venrock
D1 Capital Partners
Durable Capital Partners
Paladin Capital Group
Foresite Capital

Inscripta Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
4/5/2021 Series E $150MM raised $XXX.XX $XXX.XX
12/10/2019 Series D $175MM raised $XXX.XX $XXX.XX
4/19/2019 Series C-1 $50MM raised $XXX.XX $XXX.XX
2/28/2018 Series C $55.5MM raised $XXX.XX $XXX.XX
2/28/2017 Series B $23.15MM raised $XXX.XX $XXX.XX
5/30/2016 Series A $6.04MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Inscripta in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM